Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Olofsson

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Biochemical Society Transactions|July 27, 2005
RhoGDI-3, a promising system to investigate the regulatory function of rhoGDIs: uncoupling of inhibitory and shuttling functions of rhoGDIsE Dransart, A Morin, J Cherfils, et al.
Current Opinion in Biotechnology|December 22, 1999
Current biology of VEGF-B and VEGF-CB Olofsson, M Jeltsch, U Eriksson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 22, 2007
Evaluation of a fall-prevention program in older people after femoral neck fracture: a one-year follow-upM Berggren, M Stenvall, B Olofsson, et al.
Journal of Neuroscience Research|March 1, 1989
Developmental and regional regulation of rab3: a new brain specific "ras-like" geneJ Ayala, B Olofsson, A Tavitian, et al.
Cancer Research|June 1, 1992
Overexpression of the ras-related rab2 gene product in peripheral blood mononuclear cells from patients with hematological and solid neoplasmsS Culine, N Honoré, A Tavitian, et al.
Acta Oto-Laryngologica. Supplementum|January 1, 1982
Epidemiology of acute otitis media in childrenL Ingvarsson, K Lundgren, B Olofsson, et al.
Blood Pressure|April 21, 2017
Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained TolerabilityD Elmfeldt, M George, R Hübner, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 30, 2011
Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazideJ G Aberg, B Olofsson, B W Karlson
Circulation Research|November 26, 1999
Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endotheliaA Lymboussaki, B Olofsson, U Eriksson, et al.
Journal of Human Hypertension|October 23, 1997
Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effectD Elmfeldt, M George, R Hübner, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Biochemical Society Transactions|July 27, 2005
RhoGDI-3, a promising system to investigate the regulatory function of rhoGDIs: uncoupling of inhibitory and shuttling functions of rhoGDIsE Dransart, A Morin, J Cherfils, et al.
Current Opinion in Biotechnology|December 22, 1999
Current biology of VEGF-B and VEGF-CB Olofsson, M Jeltsch, U Eriksson, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 22, 2007
Evaluation of a fall-prevention program in older people after femoral neck fracture: a one-year follow-upM Berggren, M Stenvall, B Olofsson, et al.
Journal of Neuroscience Research|March 1, 1989
Developmental and regional regulation of rab3: a new brain specific "ras-like" geneJ Ayala, B Olofsson, A Tavitian, et al.
Cancer Research|June 1, 1992
Overexpression of the ras-related rab2 gene product in peripheral blood mononuclear cells from patients with hematological and solid neoplasmsS Culine, N Honoré, A Tavitian, et al.
Acta Oto-Laryngologica. Supplementum|January 1, 1982
Epidemiology of acute otitis media in childrenL Ingvarsson, K Lundgren, B Olofsson, et al.
Blood Pressure|April 21, 2017
Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained TolerabilityD Elmfeldt, M George, R Hübner, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 30, 2011
Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazideJ G Aberg, B Olofsson, B W Karlson
Circulation Research|November 26, 1999
Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endotheliaA Lymboussaki, B Olofsson, U Eriksson, et al.
Journal of Human Hypertension|October 23, 1997
Candesartan cilexetil, a new generation angiotensin II antagonist, provides dose dependent antihypertensive effectD Elmfeldt, M George, R Hübner, et al.
Pageof 9